Compliant concept: financing round and success in the market

Please login or
register
17.01.2013

The first product to hit the Swiss market from compliant concept is surpassing all expectations. The successful market launch of the electronic healthcare assistant also impressed investors.

In July 2012, compliant concept launched its first product: the mobility monitor. For the first time, it is possible to obtain objective information about sleep patterns and mobility. As well as benefiting those in need of care, the new possibilities offered by this product are of particular assistance to nurses and caretakers. The "Mobility Monitor" supports nurses and caretakers in their decision-making processes and contributes to the efficient planning, design and documentation of care.
 
According to CEO Michael Sauter, feedback from the first customers was overwhelming, with the monitor being used in a much more versatile manner than originally anticipated. In the first quarter after sales commenced, the company had already generated over 50 percent higher sales than had been forecast in the business plan. The first customers were already buying additional devices and the company had succeeded in obtaining a contract from the TERTIANUM Group – one of the market leaders – for use of the Mobility Monitor in all their residences. From the beginning of 2013, the Mobility Monitor will also be distributed in Germany and Sauter reports that discussions are already being held with partners in other countries.
 
Both the idea and the product have convinced investors. Sauter recently completed the first round of financing. Now, he not only has the support of various private investors, but is also backed by institutional investors – Lausanne-based pharmaceutical development group Debiopharm, Zürcher Kantonalbank (Cantonal Bank of Zurich) and Empa, the Swiss Federal Laboratories for Materials Science and Technology.

"I am delighted with the excellent investment structure. We now benefit not only from the capital these investors are providing, but also from their expertise and huge networks", comments Sauter. Thierry Mauvernay, Debiopharm Group's Delegate of the Board adds: "The start-up spirit is greatly valued by Debiopharm. We want to foster and sustain it by supporting other entrepreneurs over the long term. compliant concept corresponds to our idea of the medicine for the future, where prevention reduces healthcare costs as well as the suffering of the most fragile patients."
 
The newly injected capital will enable compliant concept to grow further and expand into other countries.

compliant concept is a spinoff of EMPA Dübendorf and the ETH Zurich, bringing new systems on to the market that ease the workload of nurses and caretakers, and guarantee constant, high-quality care are more in demand than ever. The company was founded in 2009 and is based in Dübendorf. compliant concept was awarded the CTI Start-up label in 2012.

0Comments

More news about

compliant concept AG

Company profiles on startup.ch

compliant concept AG

rss